|
Procter & Gamble Health Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
11524.12 Cr.
|
P/BV
|
21.97
|
Book Value (Rs.)
|
316.01
|
|
52 Week High/Low (Rs.)
|
6950/4707
|
FV/ML
|
10/1
|
P/E(X)
|
35.25
|
|
Bookclosure
|
21/08/2026
|
EPS (Rs.)
|
196.94
|
Div Yield (%)
|
0.65
|
|
(Rs. in Crs.)
| Months | 12 | 9 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1407.97 | 918.09 | 1129.49 | 1205.86 | 1092.04 |
| Other Operating Revenues | 0.00 | 16.08 | 21.77 | 23.76 | 22.37 |
| Total Operating Revenues | 1407.97 | 934.17 | 1151.26 | 1229.62 | 1114.41 |
| | | | | | |
| Other Income | 17.34 | 10.35 | 15.63 | 18.39 | 13.19 |
| Total Revenue | 1425.31 | 944.52 | 1166.89 | 1248.01 | 1127.60 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 307.33 | 200.59 | 290.23 | 319.23 | 323.72 |
| Purchase Of Stock-In Trade | 70.58 | 47.16 | 39.46 | 39.76 | 20.83 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -12.83 | 14.75 | 0.87 | 2.85 | -4.75 |
| Employee Benefit Expenses | 222.56 | 142.06 | 215.16 | 206.17 | 167.56 |
| Finance Costs | 0.55 | 0.43 | 0.72 | 0.77 | 0.42 |
| Provisions And Contingencies | 0.00 | 0.00 | 0.00 | -0.73 | 0.73 |
| Depreciation And Amortisation Expenses | 23.59 | 16.69 | 27.40 | 28.10 | 27.08 |
| Other Expenses | 363.67 | 211.22 | 299.54 | 337.66 | 338.64 |
| Total Expenses | 975.45 | 632.90 | 873.38 | 933.81 | 874.23 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 449.86 | 311.62 | 293.51 | 314.20 | 253.37 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | -20.19 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 449.86 | 311.62 | 273.32 | 314.20 | 253.37 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 122.95 | 77.63 | 79.10 | 86.61 | 65.02 |
| Deferred Tax | 0.00 | -0.49 | -8.60 | -5.06 | 0.04 |
| Tax For Earlier Years | 0.00 | 0.07 | 1.84 | 3.18 | -4.21 |
| Total Tax Expenses | 122.95 | 77.21 | 72.34 | 84.73 | 60.85 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 326.91 | 234.41 | 200.98 | 229.47 | 192.52 |
| | | | | | |
| Profit/Loss From Continuing Operations | 326.91 | 234.41 | 200.98 | 229.47 | 192.52 |
| | | | | | |
| Profit/Loss For The Period | 326.91 | 234.41 | 200.98 | 229.47 | 192.52 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 196.94 | 141.00 | 133.00 | 138.00 | 116.00 |
| Diluted EPS (Rs.) | 196.94 | 141.00 | 121.00 | 138.00 | 116.00 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 232.40 | 414.99 | 93.79 | 283.85 |
| Equity Dividend Rate (%) | 450.00 | 1250.00 | 2600.00 | 950.00 | 525.00 |
